Results 111 to 120 of about 5,269 (122)

Triggering and resolution of inflammation in NASH

Nature Reviews Gastroenterology and Hepatology, 2018
Daniel Cabrera, Marco Arrese, Ariel E Feldstein   +2 more
exaly  

Noninvasive biomarkers in NAFLD and NASH — current progress and future promise

Nature Reviews Gastroenterology and Hepatology, 2018
Vincent Wai-Sun Wong, Victor de Lédinghen, Grace Lai-Hung Wong   +2 more
exaly  

Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer

Nature Medicine, 2019
Mohsen Malehmir, Dominik Pfister, Suchira Gallage   +2 more
exaly  

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

Nature Reviews Gastroenterology and Hepatology, 2017
Zobair M Younossi, Quentin M Anstee, Frcp, Milena Marietti   +2 more
exaly  

Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH

Hepatology, 2013
Lixin Zhu
exaly  

NAFLD, NASH and liver cancer

Nature Reviews Gastroenterology and Hepatology, 2013
Gregory A Michelotti, Anna Mae Diehl
exaly  

Noninvasive, Quantitative Assessment of Liver Fat by MRI‐PDFF as an Endpoint in NASH Trials

Hepatology, 2018
Cyrielle Caussy, Scott B Reeder, Claude B Sirlin   +2 more
exaly  

Lipotoxicity and the gut-liver axis in NASH pathogenesis

Journal of Hepatology, 2018
Fabio Marra, Gianluca Svegliati-Baroni
exaly  

Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD

Journal of Hepatology, 2017
Hannes Hagström, Patrik Nasr, Mattias Ekstedt   +2 more
exaly  

Current and future pharmacological therapies for NAFLD/NASH

Journal of Gastroenterology, 2017
Yoshio Sumida
exaly